# A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine

> **NCT02693652** · PHASE1,PHASE2 · COMPLETED · sponsor: **CHA Vaccine Institute Co., Ltd.** · enrollment: 53 (actual)

## Conditions studied

- Hepatitis B, Chronic

## Interventions

- **BIOLOGICAL:** CVI-HBV-002

## Key facts

- **NCT ID:** NCT02693652
- **Lead sponsor:** CHA Vaccine Institute Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10-28
- **Primary completion:** 2017-08-22
- **Final completion:** 2017-08-22
- **Target enrollment:** 53 (ACTUAL)
- **Last updated:** 2023-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02693652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02693652, "A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02693652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*